Consolidated Statements of Operations - USD ($) shares in Thousands, $ in Thousands	12 Months Ended
	Jan. 30, 2021	Feb. 01, 2020	Feb. 02, 2019
Income Statement [Abstract]
Sales	$ 318,946	$ 474,038	$ 473,756
Cost of goods sold including occupancy costs	214,081	269,837	262,467
Gross profit	104,865	204,201	211,289
Expenses:
Selling, general and administrative	129,062	180,663	183,868
Exit costs associated with London operations		1,737
CEO transition costs		743	2,404
Corporate restructuring charge			1,904
Impairment of assets	14,841	889	4,579
Depreciation and amortization	21,477	24,563	28,653
Total expenses	165,380	208,595	221,408
Operating loss	(60,515)	(4,394)	(10,119)
Interest expense, net	(3,917)	(3,297)	(3,462)
Loss before provision (benefit) for income taxes	(64,432)	(7,691)	(13,581)
Provision (benefit) for income taxes	106	105	(50)
Net loss	$ (64,538)	$ (7,796)	$ (13,531)
Net loss per share - basic and diluted	$ (1.26)	$ (0.16)	$ (0.28)
Weighted-average number of common shares outstanding:
Basic and diluted	51,317	49,992	49,163